Literature DB >> 18256268

Cholinergic-mediated IP3-receptor activation induces long-lasting synaptic enhancement in CA1 pyramidal neurons.

David Fernández de Sevilla1, Angel Núñez, Michel Borde, Roberto Malinow, Washington Buño.   

Abstract

Cholinergic-glutamatergic interactions influence forms of synaptic plasticity that are thought to mediate memory and learning. We tested in vitro the induction of long-lasting synaptic enhancement at Schaffer collaterals by acetylcholine (ACh) at the apical dendrite of CA1 pyramidal neurons and in vivo by stimulation of cholinergic afferents. In vitro ACh induced a Ca2+ wave and synaptic enhancement mediated by insertion of AMPA receptors in spines. Activation of muscarinic ACh receptors (mAChRs) and Ca2+ release from inositol 1,4,5-trisphosphate (IP3)-sensitive stores were required for this synaptic enhancement that was insensitive to blockade of NMDA receptors and also triggered by IP3 uncaging. Activation of cholinergic afferents in vivo induced an analogous atropine-sensitive synaptic enhancement. We describe a novel form of synaptic enhancement (LTP(IP3)) that is induced in vitro and in vivo by activation of mAChRs. We conclude that Ca2+ released from postsynaptic endoplasmic reticulum stores is the critical event in the induction of this unique form of long-lasting synaptic enhancement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18256268      PMCID: PMC6671582          DOI: 10.1523/JNEUROSCI.2723-07.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  51 in total

1.  M-type potassium channels modulate Schaffer collateral-CA1 glutamatergic synaptic transmission.

Authors:  Jianli Sun; Jaideep Kapur
Journal:  J Physiol       Date:  2012-06-06       Impact factor: 5.182

2.  The muscarinic long-term enhancement of NMDA and AMPA receptor-mediated transmission at Schaffer collateral synapses develop through different intracellular mechanisms.

Authors:  David Fernández de Sevilla; Washington Buño
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

3.  Enhanced dendritic spine number of neurons of the prefrontal cortex, hippocampus, and nucleus accumbens in old rats after chronic donepezil administration.

Authors:  Faviola Alcantara-Gonzalez; Ismael Juarez; Oscar Solis; Isaura Martinez-Tellez; Israel Camacho-Abrego; Eliezer Masliah; Raul Mena; Gonzalo Flores
Journal:  Synapse       Date:  2010-10       Impact factor: 2.562

Review 4.  ER calcium and Alzheimer's disease: in a state of flux.

Authors:  Mark P Mattson
Journal:  Sci Signal       Date:  2010-03-23       Impact factor: 8.192

Review 5.  Understanding calcium waves and sparks in central neurons.

Authors:  William N Ross
Journal:  Nat Rev Neurosci       Date:  2012-02-08       Impact factor: 34.870

6.  Activation of InsP₃ receptors is sufficient for inducing graded intrinsic plasticity in rat hippocampal pyramidal neurons.

Authors:  Sufyan Ashhad; Daniel Johnston; Rishikesh Narayanan
Journal:  J Neurophysiol       Date:  2014-12-30       Impact factor: 2.714

7.  Lasting modulation of in vitro oscillatory activity with weak direct current stimulation.

Authors:  Davide Reato; Marom Bikson; Lucas C Parra
Journal:  J Neurophysiol       Date:  2014-12-10       Impact factor: 2.714

8.  M1 muscarinic activation induces long-lasting increase in intrinsic excitability of striatal projection neurons.

Authors:  Xiaohui Lv; Jonathan W Dickerson; Jerri M Rook; Craig W Lindsley; P Jeffrey Conn; Zixiu Xiang
Journal:  Neuropharmacology       Date:  2017-03-20       Impact factor: 5.250

9.  Postsynaptic activity reverses the sign of the acetylcholine-induced long-term plasticity of GABAA inhibition.

Authors:  Soledad Domínguez; David Fernández de Sevilla; Washington Buño
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-17       Impact factor: 11.205

10.  Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice.

Authors:  Latha Devi; Masuo Ohno
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.